XI Simposio Médico Anual de ECD, Birmingham (Alabama)

Dr. Gaurav Goyal
Universidad de Alabama en Birmingham
Birmingham, Alabama US
1 de mayo de 2026

Birmingham Medical Symposium Group Picture 2026

Resumen del simposio

Approximately 44 medical professionals from 6 countries attended the Annual ECD Medical Symposium in 2026. 15 oral abstracts were presented, along with an additional 9 poster presentations. The keynote speaker, Nicole Coufal, MD, PhD, delivered a talk titled “Diversity and Degeneration in Neurohistiocytic Disease.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Programas con el orden del día del simposio

Orden del día

PresentadorDiapositivas de la presentaciónVídeo en inglés
Dr. Gaurav GoyalVer diapositivaBienvenidos a Birmingham y a la XI Conferencia Internacional Anual sobre la Enfermedad de Erdheim-Chester
Nicole Coufal, MD (Keynote Speaker)Ver diapositivaDiversidad y degeneración en la enfermedad neurohistiocítica
Dr. Benjamin DurhamVer diapositivaLas mutaciones en el gen ARAF provocan neoplasias histiocíticas in vivo y aportan información sobre su origen celular
Florian Houdu, MDVer diapositivaTracking BRAF V600E Persistence under MEK Inhibition in Histiocytoses: a B-cell–enriched signal
Irena Ungureanu, MDVer diapositivaDistribution of MAP2K1 Variants Across Peripheral Blood Cells in Erdheim-Chester Disease and Other Histiocytoses
Dr. Matthew CollinVer diapositivaThe Clonal Origin and Evolution of High-Risk Multisystem Histiocytosis in Adults
Dongni Yi, MDVer diapositivaMutaciones del gen KRAS en las neoplasias histiocíticas: espectro de mutaciones y respuesta a la inhibición de MEK
Dongni Yi, MDVer diapositivaLa sobreexpresión de la ciclina D1 provoca estrés replicativo y genera vulnerabilidades terapéuticas en las neoplasias histiocíticas
Jérôme Razanamahery, MDVer diapositivaClonal Hematopoiesis Predicts Response to Interferon-α in Erdheim-Chester Disease and Myeloproliferative Neoplasms
Félicien Triboulet, MDVer diapositivaImpact of Additional Genetic Variants in the Course of Erdheim-Chester Disease… a Multicentric Longitudinal Study of 445 French Patients
Guneet Janda, MDVer diapositivaPatterns of Presentation and Outcomes in Adults Xanthogranulomas
Mustafa Abomohsen, MDVer diapositivaNo disponible
Carla Isabel Borre, MDVer diapositivaReal World Frontline Systemic Anti-Cancer Treatment Patterns and Outcomes in Erdheim–Chester Disease
Dr. Gaurav GoyalVer diapositivaBurden of Chronic Health Conditions After Diagnosis of Erdheim–Chester Disease (ECD): Early Results from the Histiocytic Disorder Survivor Study
Julien Haroche, doctor en Medicina y doctor en FilosofíaVer diapositivaDestombes-Rosai-Dorfman Disease: Clinical, Molecular Characteristics and Treatment Response: data from a retrospective cohort of 107 patients
Anneka Johnston, MDVer diapositivaConsiderations for Assessment and Treatment of Neuropsychiatric Symptoms in ECD
Matthew Collin, doctor en Medicina y doctor en FilosofíaVer diapositivaAll that glitters: retro-orbital xanthogranuloma or ECD?
Dr. Jithma AbeykoonVer diapositivaLa clave estaba en la tensión arterial: enfermedad de Erdheim-Chester atípica
Jerome HensonLa Alianza Global de ECD hacia el futuroLa Alianza Global de ECD hacia el futuro

Fotografías

Cena de celebración

Simposio Médico

Recepción médica

Reunión del centro de atención